# A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865

> **NCT02138500** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 5 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** PF-06372865
- **DRUG:** PF-06372865
- **DRUG:** PF-06372865

## Key facts

- **NCT ID:** NCT02138500
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2014-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02138500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02138500, "A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02138500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*